Angela Slater
Adult Health · Florence, MSNPI 1164893921
Payments from drug & device makers
Across 706 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Merck$1K
- Bristol Myers Squibb$763
- AstraZeneca$682
- Incyte Corporation$663
- Gilead$610
- plus $9K from 54 others
What the payments were for
- Food & beverage$13,23192%
- Education$4943%
- Other$6985%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$14,424 in reported general payments places this provider in the 95th percentile of 93 adult health providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CalquenceAcalabrutinib Maleate | 15 | $171,951 |
| XtandiEnzalutamide | 11 | $134,725 |
| EliquisApixaban | 21 | $23,840 |
| Fentanyl | 43 | $5,140 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 160 | $4,884 |
| Megestrol Acetate | 62 | $3,345 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 65 | $3,108 |
| Abiraterone Acetate | 11 | $1,433 |
| Potassium Chloride | 96 | $1,373 |
| Dexamethasone | 56 | $1,278 |
| Morphine Sulfate ErMorphine Sulfate | 33 | $1,243 |
| Letrozole | 77 | $1,227 |
| Hydroxyurea | 41 | $1,049 |
| Tamoxifen Citrate | 39 | $639 |
| Oxycodone Hcl | 26 | $518 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaCalquence | $682 | $171,95115 claims |
| Astellas Pharma US IncXtandi | $219 | $134,72511 claims |
| PfizerEliquis | $406 | $23,84021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 93 adult health providers in Mississippi.
Other adult health in Florence
- Amanda GreeneRidgeland$108K
- Rhonda HickmanTupelo$15K
- Jennifer Delaney-DavisOcean Springs$9K
- Traci EvansGulfport$8K
- Casey AdamsGulfport$8K
- Keila BrownJackson$7K
- Brandi JohnstonJackson$7K
- Elizabeth WhiteHattiesburg$6K
- Jessica JonesHattiesburg$5K
- Deborah HoodJackson$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.